MedPath

Effect of two Medicines Varatika Bhasma and Abha Guggulu in Osteoporosis

Phase 3
Conditions
Health Condition 1: M800- Age-related osteoporosis with current pathological fracture
Registration Number
CTRI/2023/09/057956
Lead Sponsor
Dr Jaykishan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients were selected between the age group of 40-70 years

2.Patients of Osteoporosis diagnosed by B.M.D test (t-score < -2.5)

3.Patients having clinical features of osteoporosis - Extreme fatigue, Body pain, Pain in back, Pain in vertebra, Hip, distal forearm, tibia, Hair loss, Dorsal kyphosis, Fracture after minimal trauma

Exclusion Criteria

1.Patients below the age of 40 years and above the age of 70 years

2.Patients suffering from pathological Osteoporosis and neoplasms of the bone like osteoma and osteosarcoma

3.Hypercalcemia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
increase in Bone Mineral DensityTimepoint: On day 91
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: -
© Copyright 2025. All Rights Reserved by MedPath